共有 25 笔近期内部人交易记录记录，涉及 ArriVent BioPharma, Inc. Common Stock (AVBP), 包括 11 笔买入 和 9 笔卖出. 内部人买入总额为 $27.4M 内部人卖出总额为 $14.88M.
近期活跃的重要内部人包括 Yao Zhengbin, Kung Winston, Kastenmayer James Paul. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — AVBP
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-02-02 |
Yao Zhengbin |
President and CEO |
限制性股票授予 (RSU) |
550,000 |
$22.67 |
$12.47M |
550,000 |
| 2026-02-02 |
Kung Winston |
Chief Financial Officer |
限制性股票授予 (RSU) |
140,000 |
$22.67 |
$3.17M |
140,000 |
| 2026-02-02 |
Kastenmayer James Paul |
General Counsel |
限制性股票授予 (RSU) |
130,000 |
$22.67 |
$2.95M |
130,000 |
| 2026-02-02 |
Lachapelle Robin |
Chief Operating Officer |
限制性股票授予 (RSU) |
130,000 |
$22.67 |
$2.95M |
130,000 |
| 2026-02-02 |
Lutzker Stuart |
President of R&d |
限制性股票授予 (RSU) |
150,000 |
$22.67 |
$3.4M |
150,000 |
| 2025-12-10 |
Hillhouse Investment Management, Ltd. |
10 Percent Owner |
知情卖出 |
555,555 |
$23.37 |
$12.98M |
3,929,117 |
| 2025-07-11 |
Lachapelle Robin |
Chief Operating Officer |
期权行权（卖出） |
2,050 |
$2.28 |
$4.67K |
410 |
| 2025-06-18 |
Peterson Kristine |
Director |
限制性股票授予 (RSU) |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-06-18 |
Hohneker John |
Director |
限制性股票授予 (RSU) |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-06-18 |
Nolet Chris |
Director |
限制性股票授予 (RSU) |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-06-18 |
Parsey Merdad |
Director |
限制性股票授予 (RSU) |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-04-28 |
Parsey Merdad |
Director |
未知 |
- |
- |
- |
- |
| 2025-04-28 |
Parsey Merdad |
Director |
限制性股票授予 (RSU) |
28,346 |
$20.92 |
$593K |
28,346 |
| 2024-01-30 |
Orbimed Advisors Llc |
10 Percent Owner |
转换（卖出） |
469,615 |
- |
- |
- |
| 2024-01-30 |
Healy James |
Director |
转换（卖出） |
1,252,308 |
- |
- |
- |
| 2024-01-30 |
Gordon Carl L |
10 Percent Owner |
转换（卖出） |
821,827 |
- |
- |
- |
| 2024-01-30 |
Hillhouse Investment Management, Ltd. |
10 Percent Owner |
转换（卖出） |
4,761,903 |
- |
- |
- |
| 2024-01-25 |
Orbimed Advisors Llc |
10 Percent Owner |
未知 |
469,615 |
- |
- |
- |
| 2024-01-25 |
Healy James |
Director |
未知 |
1,252,308 |
- |
- |
- |
| 2024-01-25 |
Gordon Carl L |
10 Percent Owner |
未知 |
469,615 |
- |
- |
- |
| 2024-01-25 |
Hillhouse Investment Management, Ltd. |
10 Percent Owner |
未知 |
3,616,041 |
- |
- |
- |
| 2024-01-25 |
Kung Winston |
Chief Financial Officer |
处置 |
197,238 |
$7.76 |
$1.53M |
- |
| 2024-01-25 |
Nolet Chris |
Director |
处置 |
16,436 |
$6.24 |
$102.56K |
- |
| 2024-01-25 |
Kastenmayer James Paul |
General Counsel |
处置 |
32,873 |
$7.76 |
$255.09K |
- |
| 2024-01-25 |
Nolet Chris |
Director |
限制性股票授予 (RSU) |
17,884 |
$18.00 |
$321.91K |
17,884 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
